TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 2.796
AS - Asia 1.753
EU - Europa 1.484
SA - Sud America 401
AF - Africa 47
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.485
Nazione #
US - Stati Uniti d'America 2.717
SG - Singapore 768
CN - Cina 418
IT - Italia 335
BR - Brasile 318
RU - Federazione Russa 266
DE - Germania 262
HK - Hong Kong 240
IE - Irlanda 197
SE - Svezia 128
VN - Vietnam 124
GB - Regno Unito 57
CA - Canada 47
FI - Finlandia 45
AT - Austria 41
AR - Argentina 31
IN - India 30
FR - Francia 27
KR - Corea 26
UA - Ucraina 26
TR - Turchia 25
ZA - Sudafrica 24
NL - Olanda 23
JP - Giappone 22
ID - Indonesia 21
MX - Messico 21
PL - Polonia 20
EC - Ecuador 19
BD - Bangladesh 18
ES - Italia 18
EG - Egitto 12
PK - Pakistan 12
DK - Danimarca 11
CL - Cile 9
IQ - Iraq 9
CO - Colombia 6
IL - Israele 6
IR - Iran 6
LT - Lituania 6
PY - Paraguay 6
UZ - Uzbekistan 6
AL - Albania 5
SA - Arabia Saudita 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
JO - Giordania 4
PH - Filippine 4
AU - Australia 3
BE - Belgio 3
MA - Marocco 3
PE - Perù 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.485
Città #
Ann Arbor 509
Singapore 486
Ashburn 290
Hong Kong 240
Chandler 196
Dublin 192
Frankfurt am Main 185
Woodbridge 167
Fairfield 129
New York 92
Beijing 90
Wilmington 90
Dallas 84
Los Angeles 70
Milan 69
Hefei 58
Houston 52
Seattle 50
Princeton 48
Shanghai 48
Santa Clara 43
The Dalles 42
Cambridge 41
Ho Chi Minh City 40
Jacksonville 40
Hanoi 34
Lissone 34
São Paulo 34
Moscow 33
Munich 33
Dearborn 30
Vienna 29
Seoul 26
Buffalo 25
Altamura 23
Lawrence 22
Chicago 21
Tokyo 18
Jakarta 17
Nanjing 17
Turku 17
Warsaw 17
Brooklyn 16
London 14
Montreal 13
Nuremberg 13
Helsinki 12
Johannesburg 12
Lachine 11
Ottawa 11
Columbus 10
Rio de Janeiro 10
Rome 10
San Diego 10
Andover 9
Boardman 9
Caronno Pertusella 9
Denver 9
Orem 9
Toronto 9
Brasília 8
Hangzhou 8
Mexico City 8
Phoenix 8
Xi'an 8
Belo Horizonte 7
Campinas 7
Changsha 7
Chennai 7
Curitiba 7
Guangzhou 7
Pavia 7
San Francisco 7
San Jose 7
Shenyang 7
Stockholm 7
Alexandria 6
Cape Town 6
Charlotte 6
Jinan 6
Melzo 6
Quito 6
Roubaix 6
Tashkent 6
Bologna 5
Boston 5
Council Bluffs 5
Detroit 5
Florence 5
Kent 5
Lahore 5
Lappeenranta 5
Poplar 5
Pune 5
Salt Lake City 5
Santo André 5
Tampa 5
Tel Aviv 5
Tirana 5
Ankara 4
Totale 4.221
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 308
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 304
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 271
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 264
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 246
Neutrophil Extracellular Traps in the Autoimmunity Context 241
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 231
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 229
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 227
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 224
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 221
Novel Therapies in Takayasu Arteritis 216
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 207
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 193
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 192
Immunology of membranous nephropathy: From animal models to humans 187
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 185
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 179
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 172
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 170
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 166
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 166
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 164
Evidence for charge-based mimicry in anti dsDNA antibody generation 162
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 162
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 159
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 156
ANCA-associated vasculitides (AAV) from the gender point of view 153
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 147
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 137
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 135
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 133
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 120
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 117
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 96
Totale 6.640
Categoria #
all - tutte 23.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021412 0 0 0 0 0 65 76 41 52 75 44 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20262.017 442 208 305 406 455 201 0 0 0 0 0 0
Totale 6.640